Bridget C.E. Dooling
Economics, Econometrics and Finance · The Ohio State University
Publications
22
Citations
180
Est. group size
—
Recurring co-author estimate
Active years
21
Publishing since 2005
Bridget C.E. Dooling studies how government agencies write and review regulations, with particular attention to U.S. bodies like the Office of Information and Regulatory Affairs (OIRA) and the Government Accountability Office (GAO). A second strand of her work examines how COVID-19-era regulatory changes affected access to opioid use disorder treatments such as methadone and buprenorphine. Her research blends legal analysis with empirical and policy evaluation methods.
Output has been variable but has picked up in recent years, rising from occasional single-paper years earlier in the decade to a peak of five publications in 2023 and several more in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Applying the <i>Regulatory Report Card</i> to Tax Regulations
Journal of Benefit-Cost Analysis · 2025
- Ghostwriting the Government
SSRN Electronic Journal · 2025
- Spending, regulations and DOGE: Office of Management and Budget director plays vital role helping government get stuff done
2025
- Corner Post, Caremark and the Rule of Law: When Corporate Fiduciaries Should Reject Corner Post's Invitation to Sue
SSRN Electronic Journal · 2025
- Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19
International Journal of Drug Policy · 2024
- Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
The Lancet Public Health · 2023
- Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States
Health Affairs Scholar · 2023
- Beyond republicans and the disapproval of regulations: A new empirical approach to the Congressional Review Act
Journal of Empirical Legal Studies · 2023
- Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S
medRxiv · 2023
- Pre-Analysis Research Plan for OIRA Review of Treasury Regulations Project
SSRN Electronic Journal · 2023
- Synthesizing evidence on the impacts of COVID-19 regulatory changes on methadone treatment for opioid use disorder: Implications for U.S. federal policy
medRxiv · 2022
- Regulatory Body Shops
SSRN Electronic Journal · 2022
- Methadone's Regulatory Thicket
SSRN Electronic Journal · 2022
- Into the Void: GAO's Role in the Regulatory State
SSRN Electronic Journal · 2020
- Bespoke Regulatory Review
SSRN Electronic Journal · 2020
- SSRN Electronic Journal×10
- medRxiv×2
- The Lancet Public Health×1
- Health Affairs Scholar×1
- International Journal of Drug Policy×1
- Sarah B. Lawsky
Economics, Econometrics and Finance · Indiana University
- Alex Acs
Economics, Econometrics and Finance · The Ohio State University
- Nicholas Almendares
Economics, Econometrics and Finance · Indiana University
- Amy Farmer
Economics, Econometrics and Finance · The Ohio State University
- Eric Rasmusen
Economics, Econometrics and Finance · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile